Information regarding the Nifty Pharma index's valuation and Price-to-Earnings (PE) ratio.

the Nifty Pharma value and its corresponding Price-to-Earnings (PE) ratio?

The Nifty Pharma index is trading in the red today, down by roughly 1.09% at 23,951.35 as of early afternoon trading on June 2, 2026. Profit-booking and broad-based sectoral headwinds have contributed to the downswing, marking the index's third consecutive session of decline.

Daily Intraday Key MetricsOpening Price: 24,102.95Previous Close: 24,214.25Intraday High: 24,171.55Intraday Low: 23,796.6552-Week Range: 21,149.90 – 25,043.15

Leading Constituents & Market ActionMajor heavyweights within the 20-stock pharmaceutical basket are facing downward pressure today:

Sun Pharma: Trading at ₹1,803.50, down 2.21%.Divi's Laboratories: Trading at ₹6,682.00, down 1.70%.Torrent Pharma: Trading at ₹4,418.00, down 2.45%.Cipla: Trading at ₹1,400.00, down 1.28%.Dr. Reddy's Laboratories: Remaining relatively flat, edge up 0.08% at ₹1,320.00.

Wockhardt: Seeing the steepest contraction among sector peers, slipping over 8% in intraday trading.

Market ContextWhile the broader Indian equity market has pared some of its early morning losses thanks to a strong rally in Information Technology (IT) shares, the defensive healthcare and financial spaces continue to drag. Ongoing geopolitical cues from West Asia and regulatory themes continue to keep sectoral sentiment cautious.